Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
you really think this has more room to run after 800% move and rs approved by board!?
https://www.otcmarkets.com/filing/html?id=15227434&guid=-4Swkqs6zY8IOth
The Majority Shareholders have approved an amendment to our Certificate to amend the Company Name and effect a Reverse Stock Split at an exchange ratio in the range of one-for-20 to one-for-40 as the Board may determine. On September 13, 2021, the Board set the ratio at one-for-40.
you can't make this chit up! it's in the filing!
is the r/s been canceled?
The Majority Shareholders have approved an amendment to our Certificate to amend the Company Name and effect a Reverse Stock Split at an exchange ratio in the range of one-for-20 to one-for-40 as the Board may determine. On September 13, 2021, the Board set the ratio at one-for-40.
https://www.otcmarkets.com/filing/html?id=15227434&guid=-4Swkqs6zY8IOth
already dumping on news lol 50 atm lol that "009 guy" is pumping it on twitter be careful!
$SEAC 2.3% put her @ $2.34 plus short covering(56%) We might see $3+ out of this!
$SEAC massive 56.72% short
Dark Pool Short Volume 61,482,222 shares - source: FINRA
Dark Pool Short Volume Ratio 56.72% - source: FINRA
SEAC massive 56.72% short
Dark Pool Short Volume 61,482,222 shares - source: FINRA
Dark Pool Short Volume Ratio 56.72% - source: FINRA
HUGE MERGER $SEAC WOW!!
Triller owner in merger talks to go public
https://www.reuters.com/markets/deals/triller-owner-merger-talks-go-public-source-2021-12-14/
SEAC WOWsers! Triller owner in merger talks to go public thru SEAC -source
https://www.reuters.com/markets/deals/triller-owner-merger-talks-go-public-source-2021-12-14/
$ANIX Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant PR Newswire "Press Releases US - English"
SAN JOSE, Calif. and STUTTGART, Germany , Dec. 7, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced the results of a genomic variant analysis done with its partner, MolGenie, GmbH , on potential compounds to treat COVID-19. The data indicate that the compounds in development should be effective against the Omicron variant of SARS-CoV-2, in addition to the previously identified Delta variant of the virus.
"Anixa's COVID-19 program is designed to identify compounds that will be effective against all variants. As new variants of concern arise, we continually seek to analyze them to determine if our compounds may be effective against them," said Dr. Amit Kumar , President and CEO of Anixa Biosciences . "We previously conducted an analysis suggesting our compounds would be effective against the Delta variant and are pleased that the results from our latest analysis indicate that they should also be effective against the Omicron variant. The threat of COVID-19 and emerging variants is very real and Anixa will continue to modify our strategy as needed to support ongoing efforts to combat the virus."
While vaccination has proven to be an effective strategy to prevent COVID-19, the need still exists for inexpensive, room-temperature-stable and orally-bioavailable therapeutics. Anixa and MolGenie are developing compounds for the potential treatment of COVID-19 with the long-term goal of developing an inexpensive, orally-administered room temperature-stable pill for the outpatient setting. The program focuses on identifying novel, small molecule inhibitors of Mpro, the main protease of the SARS-CoV-2 virus, which is necessary for replication. The current compounds that Anixa and MolGenie have synthesized and tested have demonstrated the ability to inhibit the function of this protein with excellent potency comparable to and in one case better than authorized therapies.
In order to evaluate the efficacy of these compounds against the Omicron variant, Anixa and MolGenie performed an analysis of the corresponding Mpro enzyme of the variant. The Omicron variant incorporates over 50 mutations, including more than 30 in the spike protein. Several of these mutations are found in the receptor binding domain. However, no significant mutations are found in or near the active site of the Mpro enzyme, therefore Anixa believes its compounds should be effective against this variant.
Dr. Lutz Weber , President and Chief Executive Officer of MolGenie, added, "We have identified and synthesized several compounds that exhibit potency against the Mpro enzyme in in-vitro biological assays. We are now initiating comprehensive pharmacokinetic analyses of these compounds to evaluate their suitability as therapies. We look forward to continuing to work with Anixa on developing a therapy that would add to the arsenal needed to combat this virus."
will take months before this closes (If) all was approved!
The Agreement contains customary representations, warranties and covenants made by each of the Company, Gix Media and Merger Sub. Consummation of the Merger is subject to certain closing conditions, including, among other things,
(i) the Company filing an amendment to its certificate of incorporation to change the Company’s name to “Gix Media, Inc.”,
(ii) obtaining approval from certain third parties, including the approval of Bank Leumi due to certain liens registered in its favor against ordinary shares of Gix Media;
(iii) conversion of the Company’s outstanding convertible instruments into restricted common stock of the Company and
(iv) obtaining a tax pre-ruling from the Israeli Tax Authority relating to the Agreement. In addition, the closing of the Agreement is subject to and conditioned upon the approval of the shareholders of Gix Media and Merger Sub.
ELEK $7.83 what a move!
Market Cap at $3.2 billion! unbelievable! congrats guys and good luck to anyone still in at these ranges!
good to see money starting to flow into otc
Market cap reached $1.930 BILLION USD Today!!!! what the co worth? I don't see any financials! $4.73 X408,503,191= $1.93 billion USD!!!!!
very nice mover! keep in mind the 37.5 million offering at 0.0975
http://archive.fast-edgar.com/20211022/AKL2G22CZ22AM2Z2222N22ZVRBIQEZ228232/
CNGT 0.0053 8-K out New directors appointed!
Jim Morrison was previously President of L'Oréal for 9 years, he acquired Redken and Matrix and led a top-line growth average above 20%. As CEO, he headed the first celebrity-driven video shopping app in partnership with SPRINT; Graham Webb, one of the most successful startups in hair care; and Sexy Hair Concepts for four years. He has served as President/CEO and a Director of Regen Biowellness, Inc., (formerly Availa Bio, Inc.), since May 2020, a health and wellness product provider.
Dr. Babak “Bobby” Ghalili, DMD, is one of the foremost periodontal and reconstructive dental surgeons in the field, he is an Associate Professor of Periodontal Surgery at New York University and the University of Medicine and Dentistry of New Jersey. Dr. Ghalili is a graduate of Brandeis University, Tufts University, and UMDMJ, and author of 21 patents (6 awarded patents and 15 patent pending).
Effective as of November 9, 2021, the following has resigned as a Director of the Registrant but shall remain as Vice President of Operations/Compliance reporting directly to the Board of Directors.
http://archive.fast-edgar.com/20211110/A62ZB22CZ222KJZ2222R2ZYZGDMBZYE28N32/cngt8k.htm
What action was taken by written consent?
We obtained stockholder consent for an amendment to our articles of incorporation to effect a reverse stock split of our common stock by a ratio of not less than 1-for-100 and not more than 1-for-1,000 at any time prior to the one year anniversary of filing the definitive information statement with respect to the reverse split, with the Board of Directors having the discretion as to whether or not the reverse split is to be effected, and with the exact ratio of any reverse split to be set at a whole number within the above range as determined by the Board in its discretion.
What vote was obtained to approve the amendment to the actions described in this information statement?
On September 30, 2021, we obtained the approval of Andrew Van Noy, our chief executive officer and chairman, to approve the amendment to our articles of incorporation. Mr. Van Noy is the holder of our 1,000 outstanding shares of Series H Preferred Stock, which provides him with 51% of the voting power of the Company’s stockholders.
http://archive.fast-edgar.com/20211020/AP29362CLZ225ZA222JH2ZY2MPTRZ222Y232/
pre14 1/100 reverse split filed 10-20-21 http://archive.fast-edgar.com/20211020/AP29362CLZ225ZA222JH2ZY2MPTRZ222Y232/
Every stock now is SPAC TRUMP lol
0.0110 now let’s see eod!
LOL when i see vert= convert shares!
look at vert!, keeps undercut ask aggressively!
not sure but i see vert at ask!!
note holders cashing out!!
Even 8-K dated August 6, 2020!
https://www.otcmarkets.com/filing/html?id=14317152&guid=8ZdwkeIQNuxayth
prob fake email!!
$PDGO heads-up, finally heard back from Paul Strickland and it turns out he has nothing to do with PDGO. Otcm somehow tagged his name to it and to other tickers. Doesn't mean it's a bad stock, just relaying the info from Paul.
— The Don of MMA (@DonOfMMA) October 8, 2021
$RGLG being accumulated! #MERGER #SHELL #PINK
stock deleted...gone!
Reverse split effective date Today 4:59PM protect profits quick IMO!
On September 1, 2021, the Board approved a one-for-seventy-five (1-for-75) reverse stock split of the Inspyr Common Stock (“Reverse Stock Split”). In furtherance of the Reverse Stock Split, Inspyr has filed an amended and restated certificate of incorporation (“Amended and Restated Certificate of Incorporation”) with the Secretary of State of Delaware to effect the Reverse Stock Split effective as of 4:59 p.m. Eastern Time on October 5, 2021, but the trading post Reverse Stock Split will not occur until FINRA approval is received (“Reverse Split Effective Time”).
As a result, at the Reverse Split Effective Time (and just prior to the completion of the Reorganization, subject to FINRA approval of each), each of the holders of Inspyr Common Stock will receive one (1) new share of Inspyr Common Stock for every seventy-five (75) shares such shareholder held immediately prior to the Reverse Split Effective Time. The Reverse Stock Split will also affect the Company’s outstanding stock options, warrants and other exercisable or convertible instruments and will result in the shares underlying such instruments being reduced and the exercise price being increased proportionately to the Reverse Stock Split ratio. No fractional shares will be issued as a result of the Reverse Stock Split. Any fractional shares that would have otherwise resulted from the Reverse Stock Split will be rounded up to the next whole number of shares.
As a result of the Reverse Stock Split, the number of issued and outstanding shares of Common Stock will be adjusted from 718,202,289 (assuming no change in issued and outstanding until such date) shares to approximately 9,576,030 shares. Additionally, pursuant to the terms of their Certificates of Designation, each Series of Inspyr preferred stock will have the conversion price at which shares of such applicable preferred stock may be converted into shares of Inspyr Common Stock proportionately adjusted to reflect the Reverse Stock Split. Additionally, all outstanding options, warrants and convertible debt of Inspyr will be adjusted proportionately pursuant to the Reverse Stock Split.
Upon the completion of the Reorganization immediately after, each shareholder will have such number of shares of Holding Company Common Stock and Holding Company Preferred Stock as the shareholder would have held of Inspyr immediately following the Reverse Stock Split.
http://archive.fast-edgar.com/20211005/A3ZZC22CNC22N9Z2222S2ZZY83RTZ22SK832/inspyrtherap_8k.htm
Doesn't show on otcmarkets anymore!
seems that way! no symbol change was scheduled!
PHBI #Pink Current Pharmagreen Biotech Inc. (PHBI: Pink Current) | FMW Media, Inc.’s New to The Street TV Announces its 5 TV Interviews Being Broadcasted on Fox Business Network, Tonight, Monday, October 4, 2021, at 10:30 P.M. PT and Tomorrow Night,…
I seen in the past a similar situation where the stock was halted in the middle of the day! but it does say 10-5-2021
not sure what will happen here!!!!
CUSIP Suspended! looks like symbol change is coming! possible rs as well!
If this news can't move it, then what else can???
failed bounce attempts! good luck holders!
way beyond flippers! it's like they were waiting for the press release to dump on!
But this should've went to 0.04 already! everyone can see the dump on news!
Total BS!! Major dump on news or tweet! is that RM even legit! people won't trust this BS anymore! TRUE!
Dilution on News every time! I swear!! makes go hummmmm
what would happen if didn't! in term of compliance! Thanks